TUG1 and bladder transitional cell carcinoma: In esophageal squamous cell cancer and bladder cancer, lncRNA TUG1 was involved in the occurrence of cisplatin resistance, and the development of azithromycin resistance in urothelial cancer of the bladder and acute myelogenous leukemia.